Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-300' Or cancer = '' Total: 11 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-300 breast cancer down miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
hsa-mir-300 glioblastoma down MicroRNA-300 inhibited glioblastoma progression through ROCK1.
hsa-mir-300 head and neck squamous cell carcinoma down miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
hsa-mir-300 hepatocellular carcinoma down miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
hsa-mir-300 laryngeal squamous cell carcinoma down MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1.
hsa-mir-300 laryngeal squamous cell carcinoma up Reduced miR-300 expression predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
hsa-mir-300 non-small cell lung cancer down MicroRNA-300 targets hypoxia inducible factor-3 alpha to inhibit tumorigenesis of human non-small cell lung cancer.
hsa-mir-300 oral squamous cell carcinoma down MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma by inhibiting epithelial-to-mesenchymal transition.
hsa-mir-300 osteosarcoma up Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7.
hsa-mir-300 osteosarcoma up Upregulation of miR-300 and downregulation of miR-125b act as potential predictor biomarkers in progression, metastasis, and poor prognosis of osteosarcoma.
hsa-mir-300 pancreatic cancer down MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/?-catenin signaling pathway by targeting CUL4B in pancreatic cancer ce